Document:

Exhibit 10.3

NEITHER THIS SECURITY NOR THE  SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE
HAVE  BEEN  REGISTERED  WITH  THE  SECURITIES  AND  EXCHANGE  COMMISSION  OR THE
SECURITIES   COMMISSION  OF  ANY  STATE  IN  RELIANCE  UPON  AN  EXEMPTION  FROM
REGISTRATION  UNDER THE  SECURITIES  ACT OF 1933,  AS AMENDED  (THE  "SECURITIES
ACT"),  AND,  ACCORDINGLY,  MAY NOT BE OFFERED  OR SOLD  EXCEPT  PURSUANT  TO AN
EFFECTIVE  REGISTRATION  STATEMENT  UNDER THE  SECURITIES  ACT OR PURSUANT TO AN
AVAILABLE  EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE  REGISTRATION
REQUIREMENTS  OF THE  SECURITIES  ACT AND IN ACCORDANCE  WITH  APPLICABLE  STATE
SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS
SECURITY MAY BE PLEDGED IN CONNECTION  WITH A BONA FIDE MARGIN  ACCOUNT OR OTHER
LOAN SECURED BY SUCH SECURITIES.

                          COMMON STOCK PURCHASE WARRANT

                                  STEVIA CORP.

Warrant Shares: 10,000,000                  Initial Exercise Date: June 30, 2015
                                            Issue Date: December 30, 2014

     THIS COMMON STOCK  PURCHASE  WARRANT (the  "Warrant")  certifies  that, for
value received,  ANSON INVESTMENTS  MASTER FUND LP or its assigns (the "Holder")
is entitled,  upon the terms and subject to the  limitations on exercise and the
conditions  hereinafter  set forth,  at any time on or after June 30,  2015 (the
"Initial  Exercise  Date") and on or prior to the close of business on the seven
year anniversary of the Initial Exercise Date (the  "Termination  Date") but not
thereafter,   to  subscribe  for  and  purchase  from  Stevia  Corp.,  a  Nevada
corporation (the "Company"),  up to 10,000,000  shares (as subject to adjustment
hereunder,  the "Warrant  Shares") of Common  Stock.  The purchase  price of one
share of Common Stock under this Warrant  shall be equal to the Exercise  Price,
as defined in Section 2(b).

     Section 1.  Definitions.  Capitalized  terms used and not otherwise defined
herein shall have the meanings  set forth in that  certain  Securities  Purchase
Agreement (the "Purchase Agreement"), dated December 30, 2014, among the Company
and the purchasers signatory thereto.

     Section 2. Exercise.

     a) Exercise of Warrant. Exercise of the purchase rights represented by this
Warrant may be made,  in whole or in part,  at any time or times on or after the
Initial  Exercise Date and on or before the Termination  Date by delivery to the
Company (or such other  office or agency of the Company as it may  designate  by
notice  in  writing  to the  registered  Holder  at the  address  of the  Holder
appearing on the books of the  Company) of a duly  executed  facsimile  copy (or
e-mail  attachment)  of the Notice of  Exercise in the form  annexed  hereto and

                                       1
<PAGE>
within  three (3) Trading  Days of the date said Notice of Exercise is delivered
to the  Company,  the  Company  shall have  received  payment  of the  aggregate
Exercise  Price of the shares  thereby  purchased by wire  transfer or cashier's
check drawn on a United States bank or, if  available,  pursuant to the cashless
exercise  procedure  specified in Section 2(c) below. No ink-original  Notice of
Exercise shall be required,  nor shall any medallion guarantee (or other type of
guarantee  or  notarization)  of  any  Notice  of  Exercise  form  be  required.
Notwithstanding  anything  herein  to the  contrary,  the  Holder  shall  not be
required to  physically  surrender  this Warrant to the Company until the Holder
has purchased all of the Warrant Shares available  hereunder and the Warrant has
been exercised in full, in which case,  the Holder shall  surrender this Warrant
to the Company for  cancellation  within  three (3) Trading Days of the date the
final Notice of Exercise is delivered to the Company.  Partial exercises of this
Warrant  resulting  in  purchases  of a portion  of the total  number of Warrant
Shares  available  hereunder  shall have the effect of lowering the  outstanding
number  of  Warrant  Shares  purchasable  hereunder  in an  amount  equal to the
applicable number of Warrant Shares purchased.  The Holder and the Company shall
maintain  records showing the number of Warrant Shares purchased and the date of
such  purchases.  The  Company  shall  deliver  any  objection  to any Notice of
Exercise  within one (1) Business Day of receipt of such notice.  THE HOLDER AND
ANY ASSIGNEE,  BY ACCEPTANCE  OF THIS  WARRANT,  ACKNOWLEDGE  AND AGREE THAT, BY
REASON OF THE PROVISIONS OF THIS PARAGRAPH,  FOLLOWING THE PURCHASE OF A PORTION
OF THE WARRANT  SHARES  HEREUNDER,  THE NUMBER OF WARRANT  SHARES  AVAILABLE FOR
PURCHASE  HEREUNDER AT ANY GIVEN TIME MAY BE LESS THAN THE AMOUNT  STATED ON THE
FACE HEREOF.

     b) Exercise  Price.  The exercise price per share of the Common Stock under
this Warrant shall be $0.12,  subject to  adjustment  hereunder  (the  "Exercise
Price").

     c)  Cashless  Exercise.  If  at  any  time  after  the  completion  of  the
then-applicable  holding period required by Rule 144, or any successor provision
then in effect, there is no effective Registration Statement registering,  or no
current  prospectus  available  for,  the  resale of the  Warrant  Shares by the
Holder,  then this Warrant may also be  exercised,  in whole or in part, at such
time by means of a "cashless  exercise" in which the Holder shall be entitled to
receive a number of Warrant  Shares equal to the  quotient  obtained by dividing
[(A-B) (X)] by (A), where:

     (A)  = the VWAP on the Trading Day immediately  preceding the date on which
          Holder  elects  to  exercise  this  Warrant  by means  of a  "cashless
          exercise," as set forth in the applicable Notice of Exercise;

     (B)  = the Exercise Price of this Warrant, as adjusted hereunder; and

     (X)  = the number of Warrant Shares that would be issuable upon exercise of
          this  Warrant  in  accordance  with the terms of this  Warrant if such
          exercise  were by  means of a cash  exercise  rather  than a  cashless
          exercise.

                                       2
<PAGE>
     d) Mechanics of Exercise.

          i. Delivery of Warrant Shares Upon Exercise.  Warrant Shares purchased
     hereunder  shall be  transmitted  by the  Transfer  Agent to the  Holder by
     crediting  the account of the  Holder's  prime  broker with The  Depository
     Trust  Company  through  its  Deposit or  Withdrawal  at  Custodian  system
     ("DWAC") if the Company is then a participant in such system and either (A)
     there is an effective registration statement permitting the issuance of the
     Warrant  Shares to or resale of the Warrant Shares by the Holder or (B) the
     shares  are   eligible  for  resale  by  the  Holder   without   volume  or
     manner-of-sale  limitations pursuant to Rule 144, and otherwise by physical
     delivery to the address  specified  by the Holder in the Notice of Exercise
     by the date that is three (3) Trading Day after the delivery to the Company
     of the Notice of Exercise, provided payment of the aggregate Exercise Price
     has been  received  by the Company  prior to such date of  issuance  (or by
     cashless  exercise,  if permitted)  (such date, the "Warrant Share Delivery
     Date").  The Warrant Shares shall be deemed to have been issued, and Holder
     or any other person so  designated  to be named  therein shall be deemed to
     have become a holder of record of such shares for all  purposes,  as of the
     date the Warrant  has been  exercised,  with  payment to the Company of the
     Exercise  Price  (or by  cashless  exercise,  if  permitted)  and all taxes
     required to be paid by the  Holder,  if any,  pursuant to Section  2(d)(vi)
     prior to the issuance of such shares, having been paid.

          ii. Delivery of New Warrants Upon Exercise. If this Warrant shall have
     been exercised in part,  the Company shall,  at the request of a Holder and
     upon  surrender of this Warrant  certificate,  within two Business  Days of
     delivery  of the  Warrant  Shares,  deliver  to the  Holder  a new  Warrant
     evidencing  the rights of the Holder to purchase  the  unpurchased  Warrant
     Shares  called for by this  Warrant,  which new Warrant  shall in all other
     respects be identical with this Warrant.

          iii.  Rescission  Rights.  If the Company  fails to cause the Transfer
     Agent to  transmit  to the Holder the  Warrant  Shares  pursuant to Section
     2(d)(i) by the Warrant Share Delivery  Date,  then the Holder will have the
     right to rescind such exercise.

          iv.  Compensation  for  Buy-In on Failure  to Timely  Deliver  Warrant
     Shares Upon  Exercise.  In addition to any other  rights  available  to the
     Holder, if the Company fails to cause the Transfer Agent to transmit to the
     Holder the Warrant  Shares in  accordance  with the  provisions  of Section
     2(d)(i)  above  pursuant  to an  exercise  on or before the  Warrant  Share
     Delivery  Date, and if after such date the Holder is required by its broker
     to purchase (in an open market  transaction  or  otherwise) or the Holder's
     brokerage  firm otherwise  purchases,  shares of Common Stock to deliver in

                                       3
<PAGE>
     satisfaction of a sale by the Holder of the Warrant Shares which the Holder
     anticipated  receiving  upon such exercise (a  "Buy-In"),  then the Company
     shall (A) pay in cash to the Holder the  amount,  if any,  by which (x) the
     Holder's total purchase price (including brokerage commissions, if any) for
     the shares of Common Stock so purchased  exceeds (y) the amount obtained by
     multiplying  (1) the number of Warrant Shares that the Company was required
     to deliver to the Holder in connection with the exercise at issue times (2)
     the price at which the sell order giving rise to such  purchase  obligation
     was  executed,  and (B) at the option of the Holder,  either  reinstate the
     portion of the Warrant and  equivalent  number of Warrant  Shares for which
     such exercise was not honored (in which case such exercise  shall be deemed
     rescinded)  or deliver  to the Holder the number of shares of Common  Stock
     that  would have been  issued  had the  Company  timely  complied  with its
     exercise and delivery  obligations  hereunder.  For example,  if the Holder
     purchases  Common Stock having a total purchase price of $11,000 to cover a
     Buy-In with respect to an attempted exercise of shares of Common Stock with
     an aggregate sale price giving rise to such purchase obligation of $10,000,
     under clause (A) of the immediately preceding sentence the Company shall be
     required to pay the Holder  $1,000.  The Holder  shall  provide the Company
     written notice  indicating the amounts  payable to the Holder in respect of
     the Buy-In and, upon request of the Company, evidence of the amount of such
     loss.  Nothing  herein  shall  limit a  Holder's  right to pursue any other
     remedies available to it hereunder, at law or in equity including,  without
     limitation,  a decree of specific performance and/or injunctive relief with
     respect to the Company's  failure to timely  deliver shares of Common Stock
     upon exercise of the Warrant as required pursuant to the terms hereof.

          v. No  Fractional  Shares  or  Scrip.  No  fractional  shares or scrip
     representing  fractional  shares  shall be issued upon the exercise of this
     Warrant.  As to any fraction of a share which the Holder would otherwise be
     entitled  to  purchase  upon  such  exercise,  the  Company  shall,  at its
     election, either pay a cash adjustment in respect of such final fraction in
     an amount equal to such fraction  multiplied by the Exercise Price or round
     up to the next whole share.

          vi. Charges,  Taxes and Expenses.  Issuance of Warrant Shares shall be
     made  without  charge to the Holder for any issue or transfer  tax or other
     incidental  expense in respect of the  issuance of Warrant  Shares,  all of
     which taxes and  expenses  shall be paid by the  Company,  and such Warrant
     Shares  shall be issued in the name of the  Holder or in such name or names
     as may be directed by the Holder; provided, however, that in the event that
     Warrant  Shares  are to be  issued  in a name  other  than  the name of the
     Holder,  this Warrant when surrendered for exercise shall be accompanied by
     the  Assignment  Form  attached  hereto duly executed by the Holder and the
     Company  may  require,  as a  condition  thereto,  the  payment  of  a  sum
     sufficient  to reimburse it for any transfer tax  incidental  thereto.  The

                                       4
<PAGE>
     Company shall pay all Transfer Agent fees required for same-day  processing
     of any Notice of Exercise and all fees to the Depository  Trust Company (or
     another  established  clearing  corporation  performing  similar functions)
     required for same-day electronic delivery of the Warrant Shares.

          vii.  Closing of Books.  The  Company  will not close its  stockholder
     books or records in any manner which  prevents the timely  exercise of this
     Warrant, pursuant to the terms hereof.

     e) Holder's Exercise Limitations. The Company shall not effect any exercise
of this  Warrant,  and a Holder shall not have the right to exercise any portion
of this Warrant,  pursuant to Section 2 or  otherwise,  to the extent that after
giving effect to such  issuance  after  exercise as set forth on the  applicable
Notice of Exercise,  the Holder (together with the Holder's Affiliates,  and any
other Persons  acting as a group together with the Holder or any of the Holder's
Affiliates),  would  beneficially  own in  excess  of the  Beneficial  Ownership
Limitation  (as defined  below).  For purposes of the  foregoing  sentence,  the
number of  shares  of Common  Stock  beneficially  owned by the  Holder  and its
Affiliates  shall  include the number of shares of Common  Stock  issuable  upon
exercise of this Warrant with respect to which such determination is being made,
but shall  exclude the number of shares of Common  Stock which would be issuable
upon  (i)  exercise  of the  remaining,  nonexercised  portion  of this  Warrant
beneficially  owned by the Holder or any of its  Affiliates and (ii) exercise or
conversion of the unexercised or nonconverted portion of any other securities of
the Company (including,  without limitation, any other Common Stock Equivalents)
subject to a limitation on conversion  or exercise  analogous to the  limitation
contained  herein  beneficially  owned by the  Holder or any of its  Affiliates.
Except as set forth in the  preceding  sentence,  for  purposes of this  Section
2(e),  beneficial ownership shall be calculated in accordance with Section 13(d)
of the Exchange Act and the rules and  regulations  promulgated  thereunder,  it
being  acknowledged  by the Holder that the Company is not  representing  to the
Holder that such calculation is in compliance with Section 13(d) of the Exchange
Act and the Holder is solely  responsible for any schedules required to be filed
in accordance  therewith.  To the extent that the  limitation  contained in this
Section 2(e) applies,  the  determination of whether this Warrant is exercisable
(in  relation  to  other  securities  owned  by the  Holder  together  with  any
Affiliates) and of which portion of this Warrant is exercisable  shall be in the
sole discretion of the Holder,  and the submission of a Notice of Exercise shall
be  deemed  to  be  the  Holder's  determination  of  whether  this  Warrant  is
exercisable (in relation to other  securities  owned by the Holder together with
any  Affiliates)  and of which portion of this Warrant is  exercisable,  in each
case subject to the Beneficial Ownership Limitation,  and the Company shall have
no  obligation  to verify or confirm  the  accuracy  of such  determination.  In
addition,  a determination as to any group status as contemplated above shall be
determined  in  accordance  with Section 13(d) of the Exchange Act and the rules
and regulations  promulgated  thereunder.  For purposes of this Section 2(e), in
determining the number of outstanding  shares of Common Stock, a Holder may rely
on the number of  outstanding  shares of Common  Stock as  reflected  in (A) the
Company's most recent  periodic or annual report filed with the  Commission,  as
the case may be, (B) a more recent public  announcement  by the Company or (C) a

                                       5
<PAGE>
more recent  written  notice by the Company or the Transfer  Agent setting forth
the  number of shares of Common  Stock  outstanding.  Upon the  written  or oral
request of a Holder,  the Company  shall within two Trading Days confirm  orally
and in  writing  to the  Holder  the  number  of shares  of  Common  Stock  then
outstanding. In any case, the number of outstanding shares of Common Stock shall
be determined after giving effect to the conversion or exercise of securities of
the Company,  including this Warrant,  by the Holder or its Affiliates since the
date as of which such number of outstanding shares of Common Stock was reported.
The "Beneficial  Ownership Limitation" shall be 4.99% of the number of shares of
the Common Stock outstanding  immediately after giving effect to the issuance of
shares of Common Stock issuable upon exercise of this Warrant.  The Holder, upon
notice to the  Company,  may  increase  or  decrease  the  Beneficial  Ownership
Limitation  provisions  of this  Section  2(e),  provided  that  the  Beneficial
Ownership  Limitation  in no event  exceeds 9.99% of the number of shares of the
Common Stock  outstanding  immediately  after  giving  effect to the issuance of
shares of Common Stock upon  exercise of this Warrant held by the Holder and the
provisions  of this  Section 2(e) shall  continue to apply.  Any increase in the
Beneficial  Ownership  Limitation will not be effective until the 61st day after
such notice is delivered to the Company.  The provisions of this paragraph shall
be construed and  implemented in a manner  otherwise  than in strict  conformity
with the terms of this Section 2(e) to correct  this  paragraph  (or any portion
hereof)  which may be defective  or  inconsistent  with the intended  Beneficial
Ownership  Limitation  herein  contained  or  to  make  changes  or  supplements
necessary  or  desirable  to  properly  give  effect  to  such  limitation.  The
limitations  contained in this  paragraph  shall apply to a successor  holder of
this Warrant.

     f) Call  Provision.  Subject to the  provisions  of  Section  2(e) and this
Section 2(f), if, after the 30th Trading Day immediately following the date that
the  Debentures  are no  longer  outstanding,  (i) (a) the  VWAP  for each of 20
consecutive Trading Days (the "Measurement Period," which 20 consecutive Trading
Day period shall not have commenced until after the 30th Trading Day immediately
following the date that the Debentures are no longer outstanding)  exceeds $0.30
(subject to adjustment for forward and reverse stock splits,  recapitalizations,
stock  dividends  and the like  after  the  Initial  Exercise  Date) and (b) the
average daily volume for such Measurement Period exceeds $40,000 per Trading Day
or (ii)  the  VWAP  for  each of 50  consecutive  Trading  Days  (the  "Extended
Measurement  Period,"  which 50  consecutive  Trading Day period  shall not have
commenced until after the 30th Trading Day  immediately  following the date that
the Debentures are no longer  outstanding)  exceeds $0.30 (subject to adjustment
for forward and reverse stock splits, recapitalizations, stock dividends and the
like after the Initial  Exercise Date) and (b) the average daily volume for such
Extended Measurement Period exceeds $20,000 per Trading Day and (iii) the Holder
is not in possession of any information that  constitutes,  or might constitute,
material  non-public  information  which was provided by the  Company,  then the
Company  may,  within 1  Trading  Day of the end of such  Measurement  Period or
Extended Measurement Period, as applicable,  call for cancellation of all or any
portion  of this  Warrant  for  which a  Notice  of  Exercise  has not yet  been
delivered  (such right, a "Call") for  consideration  equal to $.001 per Warrant
Share.  To  exercise  this  right,  the  Company  must  deliver to the Holder an
irrevocable written notice (a "Call Notice"),  indicating therein the portion of
unexercised  portion  of this  Warrant  to which  such  notice  applies.  If the
conditions  set forth below for such Call are satisfied from the period from the

                                       6
<PAGE>
date of the Call Notice through and including the Call Date (as defined  below),
then any portion of this Warrant  subject to such Call Notice for which a Notice
of Exercise  shall not have been  received by the Call Date will be cancelled at
6:30 p.m.  (New York City time) on the tenth Trading Day after the date the Call
Notice is  received by the Holder  (such date and time,  the "Call  Date").  Any
unexercised  portion of this  Warrant to which the Call  Notice does not pertain
will be  unaffected by such Call Notice.  In  furtherance  thereof,  the Company
covenants  and agrees that it will honor all Notices of Exercise with respect to
Warrant Shares subject to a Call Notice that are tendered through 6:30 p.m. (New
York City time) on the Call Date.  The parties agree that any Notice of Exercise
delivered  following a Call Notice which calls less than all the Warrants  shall
first  reduce to zero the number of Warrant  Shares  subject to such Call Notice
prior to reducing the remaining Warrant Shares available for purchase under this
Warrant. For example, if (A) this Warrant then permits the Holder to acquire 100
Warrant Shares,  (B) a Call Notice pertains to 75 Warrant Shares,  and (C) prior
to 6:30 p.m.  (New York City time) on the Call Date the Holder  tenders a Notice
of Exercise in respect of 50 Warrant Shares, then (x) on the Call Date the right
under this Warrant to acquire 25 Warrant Shares will be automatically cancelled,
(y) the Company,  in the time and manner required under this Warrant,  will have
issued and delivered to the Holder 50 Warrant Shares in respect of the exercises
following  receipt  of the  Call  Notice,  and (z) the  Holder  may,  until  the
Termination  Date,  exercise  this  Warrant  for 25 Warrant  Shares  (subject to
adjustment as herein provided and subject to subsequent  Call Notices).  Subject
again to the provisions of this Section 2(f), the Company may deliver subsequent
Call Notices for any portion of this Warrant for which the Holder shall not have
delivered a Notice of  Exercise.  Notwithstanding  anything to the  contrary set
forth in this Warrant,  the Company may not deliver a Call Notice or require the
cancellation  of this Warrant (and any such Call Notice shall be void),  unless,
from the beginning of the Measurement Period or the Extended Measurement Period,
as  applicable,  through the Call Date,  (1) the Company  shall have  honored in
accordance  with the terms of this Warrant all Notices of Exercise  delivered by
6:30 p.m.  (New  York  City  time) on the Call  Date,  and (2) the  Registration
Statement  shall  be  effective  as to all  Warrant  Shares  and the  prospectus
thereunder  available  for use by the Holder for the resale of all such  Warrant
Shares,  and (3) the Common  Stock  shall be listed or quoted for trading on the
Trading  Market,  and (4) there is a sufficient  number of authorized  shares of
Common Stock for issuance of all Securities under the Transaction Documents, and
(5) the  issuance  of the shares  shall not cause a breach of any  provision  of
Section 2(e) herein. The Company's right to call the Warrants under this Section
2(f) shall be exercised ratably among the Holders based on each Holder's initial
purchase of Warrants.

     Section 3. Certain Adjustments.

     a) Stock  Dividends  and  Splits.  If the  Company,  at any time while this
Warrant  is  outstanding:  (i)  pays a  stock  dividend  or  otherwise  makes  a
distribution or  distributions on shares of its Common Stock or any other equity
or equity equivalent  securities  payable in shares of Common Stock (which,  for
avoidance  of doubt,  shall not include any shares of Common Stock issued by the
Company upon exercise of this Warrant),  (ii) subdivides  outstanding  shares of
Common Stock into a larger number of shares, (iii) combines (including by way of

                                       7
<PAGE>
reverse stock split) outstanding shares of Common Stock into a smaller number of
shares or (iv)  issues by  reclassification  of shares of the  Common  Stock any
shares of capital  stock of the Company,  then in each case the  Exercise  Price
shall be multiplied by a fraction of which the numerator  shall be the number of
shares  of  Common  Stock  (excluding   treasury  shares,  if  any)  outstanding
immediately  before such event and of which the denominator  shall be the number
of shares of Common  Stock  outstanding  immediately  after such event,  and the
number of shares issuable upon exercise of this Warrant shall be proportionately
adjusted  such that the  aggregate  Exercise  Price of this Warrant shall remain
unchanged.  Any  adjustment  made  pursuant to this  Section  3(a) shall  become
effective   immediately   after  the  record  date  for  the   determination  of
stockholders  entitled to receive such dividend or distribution and shall become
effective  immediately  after the effective  date in the case of a  subdivision,
combination or re-classification.

     b) Subsequent  Equity Sales. If the Company or any Subsidiary  thereof,  as
applicable,  at any time while this Warrant is outstanding,  shall sell or grant
any option to  purchase,  or sell or grant any right to  reprice,  or  otherwise
dispose  of or issue  (or  announce  any  offer,  sale,  grant or any  option to
purchase or other disposition) any Common Stock or Common Stock Equivalents,  at
an effective  price per share less than the Exercise  Price then in effect (such
lower price, the "Base Share Price" and such issuances collectively, a "Dilutive
Issuance")  (it being  understood  and  agreed  that if the holder of the Common
Stock or Common  Stock  Equivalents  so issued  shall at any  time,  whether  by
operation of purchase price adjustments, reset provisions,  floating conversion,
exercise or exchange prices or otherwise, or due to warrants,  options or rights
per share  which are issued in  connection  with such  issuance,  be entitled to
receive shares of Common Stock at an effective price per share that is less than
the Exercise Price, such issuance shall be deemed to have occurred for less than
the  Exercise  Price on such date of the  Dilutive  Issuance  at such  effective
price),  then simultaneously with the consummation of each Dilutive Issuance the
Exercise  Price shall be reduced and only reduced to equal the Base Share Price.
Such  adjustment  shall be made  whenever  such  Common  Stock or  Common  Stock
Equivalents are issued.  Notwithstanding the foregoing,  no adjustments shall be
made,  paid or issued under this Section 3(b) in respect of an Exempt  Issuance.
The Company shall notify the Holder,  in writing,  no later than the Trading Day
following  the  issuance or deemed  issuance of any Common Stock or Common Stock
Equivalents  subject to this Section  3(b),  indicating  therein the  applicable
issuance price, or applicable reset price, exchange price,  conversion price and
other pricing terms (such notice, the "Dilutive Issuance Notice").  For purposes
of clarification, whether or not the Company provides a Dilutive Issuance Notice
pursuant to this Section 3(b), upon the occurrence of any Dilutive Issuance, the
Holder is entitled to receive the then  current  number of Warrant  Shares based
upon the Base Share Price regardless of whether the Holder  accurately refers to
the Base Share Price in the Notice of  Exercise.  If the  Company  enters into a
Variable  Rate  Transaction,  despite the  prohibition  thereon in the  Purchase
Agreement,  the Company  shall be deemed to have issued  Common  Stock or Common
Stock  Equivalents at the lowest possible  conversion or exercise price at which
such securities may be converted or exercised

     c) Subsequent Rights Offerings.  Until such time that less than 25% of this
Warrant remains outstanding,  in addition to any adjustments pursuant to Section

                                       8
<PAGE>
3(a) above, if at any time the Company grants,  issues or sells any Common Stock
Equivalents or rights to purchase stock, warrants,  securities or other property
pro rata to the  record  holders  of any class of shares  of Common  Stock  (the
"Purchase Rights"),  then the Holder will be entitled to acquire, upon the terms
applicable to such Purchase  Rights,  the  aggregate  Purchase  Rights which the
Holder could have acquired if the Holder had held the number of shares of Common
Stock  acquirable upon complete  exercise of this Warrant (without regard to any
limitations on exercise hereof,  including  without  limitation,  the Beneficial
Ownership Limitation) immediately before the date on which a record is taken for
the grant,  issuance or sale of such Purchase  Rights,  or, if no such record is
taken,  the date as of which the record holders of shares of Common Stock are to
be determined for the grant,  issue or sale of such Purchase  Rights  (provided,
however,  to the  extent  that the  Holder's  right to  participate  in any such
Purchase  Right would result in the Holder  exceeding the  Beneficial  Ownership
Limitation,  then the  Holder  shall  not be  entitled  to  participate  in such
Purchase Right to such extent (or beneficial  ownership of such shares of Common
Stock as a result of such Purchase Right to such extent) and such Purchase Right
to such extent  shall be held in  abeyance  for the Holder  until such time,  if
ever,  as its  right  thereto  would  not  result in the  Holder  exceeding  the
Beneficial Ownership Limitation).

     d) Pro Rata Distributions. During such time as this Warrant is outstanding,
if the Company shall declare or make any dividend or other  distribution  of its
assets (or rights to acquire its  assets) to holders of shares of Common  Stock,
by way of return of capital or otherwise  (including,  without  limitation,  any
distribution of cash, stock or other securities, property or options by way of a
dividend,  spin  off,  reclassification,   corporate  rearrangement,  scheme  of
arrangement or other similar transaction) (a "Distribution"),  at any time after
the  issuance of this  Warrant,  then,  in each such case,  the Holder  shall be
entitled to participate in such  Distribution to the same extent that the Holder
would have  participated  therein if the Holder had held the number of shares of
Common Stock  acquirable upon complete  exercise of this Warrant (without regard
to any  limitations  on  exercise  hereof,  including  without  limitation,  the
Beneficial Ownership  Limitation)  immediately before the date of which a record
is taken for such  Distribution,  or, if no such record is taken, the date as of
which the record  holders of shares of Common Stock are to be determined for the
participation in such Distribution  (provided,  however,  to the extent that the
Holder's  right to  participate  in any such  Distribution  would  result in the
Holder exceeding the Beneficial Ownership Limitation,  then the Holder shall not
be  entitled  to  participate  in such  Distribution  to such  extent (or in the
beneficial  ownership  of any  shares  of  Common  Stock  as a  result  of  such
Distribution to such extent) and the portion of such Distribution  shall be held
in abeyance for the benefit of the Holder until such time, if ever, as its right
thereto  would not  result in the  Holder  exceeding  the  Beneficial  Ownership
Limitation).

     e)  Fundamental  Transaction.  If,  at  any  time  while  this  Warrant  is
outstanding,  (i) the Company,  directly or  indirectly,  in one or more related
transactions  effects any merger or  consolidation  of the Company  with or into
another  Person,  (ii) the Company,  directly or  indirectly,  effects any sale,
lease, license, assignment,  transfer, conveyance or other disposition of all or
substantially  all of its  assets  in one or a series of  related  transactions,
(iii) any, direct or indirect,  purchase  offer,  tender offer or exchange offer

                                       9
<PAGE>
(whether  by the  Company or  another  Person) is  completed  pursuant  to which
holders of Common Stock are permitted to sell,  tender or exchange  their shares
for other  securities,  cash or property and has been accepted by the holders of
50% or more of the  outstanding  Common  Stock,  (iv) the  Company,  directly or
indirectly,  in one or more related transactions  effects any  reclassification,
reorganization or  recapitalization  of the Common Stock or any compulsory share
exchange  pursuant to which the Common Stock is  effectively  converted  into or
exchanged for other securities,  cash or property, or (v) the Company,  directly
or indirectly,  in one or more related transactions consummates a stock or share
purchase agreement or other business combination (including, without limitation,
a  reorganization,  recapitalization,  spin-off or scheme of  arrangement)  with
another  Person or group of Persons  whereby such other Person or group acquires
more than 50% of the  outstanding  shares of Common  Stock  (not  including  any
shares of Common Stock held by the other Person or other Persons making or party
to, or associated or affiliated  with the other Persons making or party to, such
stock  or  share  purchase  agreement  or other  business  combination)  (each a
"Fundamental Transaction"),  then, upon any subsequent exercise of this Warrant,
the Holder shall have the right to receive,  for each  Warrant  Share that would
have been  issuable upon such exercise  immediately  prior to the  occurrence of
such Fundamental Transaction, at the option of the Holder (without regard to any
limitation  in Section  2(e) on the  exercise  of this  Warrant),  the number of
shares of Common  Stock of the  successor  or  acquiring  corporation  or of the
Company, if it is the surviving  corporation,  and any additional  consideration
(the  "Alternate  Consideration")  receivable  as a result  of such  Fundamental
Transaction  by a holder of the number of shares of Common  Stock for which this
Warrant  is  exercisable  immediately  prior  to  such  Fundamental  Transaction
(without  regard to any  limitation  in  Section  2(e) on the  exercise  of this
Warrant).  For purposes of any such exercise,  the determination of the Exercise
Price shall be appropriately  adjusted to apply to such Alternate  Consideration
based on the amount of Alternate  Consideration issuable in respect of one share
of Common Stock in such Fundamental Transaction, and the Company shall apportion
the Exercise  Price among the  Alternate  Consideration  in a reasonable  manner
reflecting  the relative  value of any  different  components  of the  Alternate
Consideration.  Notwithstanding  the  foregoing,  the  following  shall  not  be
considered a  Fundamental  Transaction:  (i) any merger of the Company or any of
its  direct  or  indirect  wholly-owned  Subsidiaries  with or  into  any of the
foregoing Persons, or any  reorganization,  recapitalization or reclassification
of the Common Stock, in which holders of the Company's voting power  immediately
prior  to such  merger,  reorganization,  recapitalization  or  reclassification
continue after such merger, reorganization, recapitalization or reclassification
to hold publicly traded securities and, directly or indirectly, the voting power
of the surviving entity or entities necessary to elect a majority of the members
of the board of directors (or their  equivalent if other than a corporation)  of
such entity or entities or (ii) pursuant to a migratory  merger  effected solely
for the purpose of changing the jurisdiction of incorporation of the Company. If
holders  of Common  Stock are given  any  choice as to the  securities,  cash or
property to be received in a Fundamental  Transaction,  then the Holder shall be
given the same choice as to the  Alternate  Consideration  it receives  upon any
exercise of this Warrant following such Fundamental Transaction. Notwithstanding
anything to the  contrary and until such time that less than 25% of this Warrant
remains outstanding,  in the event of a Fundamental Transaction,  the Company or

                                       10
<PAGE>
any  Successor  Entity  (as  defined  below)  shall,  at  the  Holder's  option,
exercisable  at any  time  concurrently  with,  or  within  30 days  after,  the
consummation  of the  Fundamental  Transaction,  purchase  this Warrant from the
Holder  by paying to the  Holder  an amount of cash  equal to the Black  Scholes
Value of the  remaining  unexercised  portion of this Warrant on the date of the
consummation of such  Fundamental  Transaction.  "Black Scholes Value" means the
value of this  Warrant  based on the  Black and  Scholes  Option  Pricing  Model
obtained from the "OV" function on Bloomberg,  L.P. ("Bloomberg")  determined as
of the day of consummation of the applicable Fundamental Transaction for pricing
purposes and reflecting (A) a risk-free  interest rate corresponding to the U.S.
Treasury  rate for a period  equal to the time  between  the date of the  public
announcement of the applicable Fundamental Transaction and the Termination Date,
(B) an  expected  volatility  equal  to the  greater  of  100%  and  the 100 day
volatility  obtained  from the HVT  function on  Bloomberg as of the Trading Day
immediately  following the public  announcement  of the  applicable  Fundamental
Transaction,  (C) the underlying price per share used in such calculation  shall
be the sum of the price per share being  offered in cash, if any, plus the value
of any  non-cash  consideration,  if any,  being  offered  in  such  Fundamental
Transaction  and (D) a remaining  option time equal to the time between the date
of the public  announcement  of the applicable  Fundamental  Transaction and the
Termination  Date. The Company shall cause any successor entity in a Fundamental
Transaction in which the Company is not the survivor (the "Successor Entity") to
assume in writing all of the  obligations  of the Company under this Warrant and
the other  Transaction  Documents  in  accordance  with the  provisions  of this
Section 3(e) pursuant to written  agreements  in form and  substance  reasonably
satisfactory  to the Holder and  approved  by the Holder  (without  unreasonable
delay) prior to such  Fundamental  Transaction  and shall,  at the option of the
Holder,  deliver to the Holder in  exchange  for this  Warrant a security of the
Successor Entity evidenced by a written instrument substantially similar in form
and substance to this Warrant which is exercisable for a corresponding number of
shares  of  capital  stock  of such  Successor  Entity  (or its  parent  entity)
equivalent to the shares of Common Stock acquirable and receivable upon exercise
of this  Warrant  (without  regard to any  limitations  on the  exercise of this
Warrant) prior to such Fundamental Transaction, and with an exercise price which
applies the exercise price hereunder to such shares of capital stock (but taking
into account the relative  value of the shares of Common Stock  pursuant to such
Fundamental  Transaction  and the value of such  shares of capital  stock,  such
number of shares of capital stock and such exercise  price being for the purpose
of  protecting  the  economic  value of this  Warrant  immediately  prior to the
consummation  of  such  Fundamental   Transaction),   and  which  is  reasonably
satisfactory  in form and  substance to the Holder.  Upon the  occurrence of any
such  Fundamental  Transaction,  the  Successor  Entity shall succeed to, and be
substituted  for  (so  that  from  and  after  the  date  of  such   Fundamental
Transaction,  the provisions of this Warrant and the other Transaction Documents
referring to the "Company" shall refer instead to the Successor Entity), and may
exercise  every  right and power of the  Company  and  shall  assume  all of the
obligations  of the  Company  under  this  Warrant  and  the  other  Transaction
Documents with the same effect as if such Successor Entity had been named as the
Company herein.

     f) Calculations. All calculations under this Section 3 shall be made to the
nearest cent or the nearest 1/100th of a share, as the case may be. For purposes
of this  Section 3, the number of shares of Common Stock deemed to be issued and

                                       11
<PAGE>
outstanding  as of a given  date  shall be the sum of the  number  of  shares of
Common Stock (excluding treasury shares, if any) issued and outstanding.

     g) Notice to Holder.

          i.  Adjustment  to Exercise  Price.  Whenever  the  Exercise  Price is
     adjusted  pursuant to any  provision of this  Section 3, the Company  shall
     promptly mail to the Holder a notice setting forth the Exercise Price after
     such  adjustment  and any  resulting  adjustment  to the  number of Warrant
     Shares and setting  forth a brief  statement  of the facts  requiring  such
     adjustment.

          ii.  Notice to Allow  Exercise  by Holder.  If (A) the  Company  shall
     declare a dividend  (or any other  distribution  in  whatever  form) on the
     Common Stock,  (B) the Company shall  declare a special  nonrecurring  cash
     dividend on or a  redemption  of the Common  Stock,  (C) the Company  shall
     authorize  the  granting  to all  holders  of the  Common  Stock  rights or
     warrants to subscribe  for or purchase  any shares of capital  stock of any
     class or of any rights, (D) the approval of any stockholders of the Company
     shall be required in  connection  with any  reclassification  of the Common
     Stock,  any  consolidation  or merger to which the Company is a party,  any
     sale or transfer of all or substantially  all of the assets of the Company,
     or any compulsory share exchange whereby the Common Stock is converted into
     other securities,  cash or property, or (E) the Company shall authorize the
     voluntary  or  involuntary  dissolution,  liquidation  or winding up of the
     affairs of the Company,  then, in each case,  the Company shall cause to be
     mailed  to the  Holder  at its last  address  as it shall  appear  upon the
     Warrant  Register of the  Company,  at least 20 calendar  days prior to the
     applicable record or effective date hereinafter specified, a notice stating
     (x) the date on  which a record  is to be  taken  for the  purpose  of such
     dividend,  distribution,  redemption, rights or warrants, or if a record is
     not to be taken,  the date as of which the  holders of the Common  Stock of
     record to be entitled to such dividend,  distributions,  redemption, rights
     or  warrants  are  to  be   determined  or  (y)  the  date  on  which  such
     reclassification,  consolidation,  merger, sale, transfer or share exchange
     is expected to become  effective  or close,  and the date as of which it is
     expected  that  holders of the Common  Stock of record shall be entitled to
     exchange  their  shares of the Common Stock for  securities,  cash or other
     property  deliverable upon such  reclassification,  consolidation,  merger,
     sale,  transfer or share  exchange;  provided that the failure to mail such
     notice or any defect therein or in the mailing thereof shall not affect the
     validity of the corporate  action  required to be specified in such notice.
     To the extent that any notice  provided  in this  Warrant  constitutes,  or
     contains, material,  non-public information regarding the Company or any of
     the Subsidiaries,  the Company shall  simultaneously  file such notice with
     the  Commission  pursuant to a Current Report on Form 8-K. The Holder shall
     remain  entitled to exercise this Warrant  during the period  commencing on

                                       12
<PAGE>
     the date of such notice to the effective date of the event  triggering such
     notice except as may otherwise be expressly set forth herein.

     Section 4. Transfer of Warrant.

     a)  Transferability.  Subject to compliance with any applicable  securities
laws and the  conditions  set forth in Section 4(d) hereof and to the provisions
of Section 4.1 of the Purchase Agreement,  this Warrant and all rights hereunder
are  transferable,  in whole or in part,  upon  surrender of this Warrant at the
principal office of the Company or its designated agent, together with a written
assignment  of this  Warrant  substantially  in the form  attached  hereto  duly
executed by the Holder or its agent or attorney and funds  sufficient to pay any
transfer  taxes payable upon the making of such  transfer.  Upon such  surrender
and, if required,  such  payment,  the Company  shall  execute and deliver a new
Warrant or Warrants in the name of the assignee or assignees, as applicable, and
in the denomination or denominations specified in such instrument of assignment,
and shall  issue to the  assignor a new Warrant  evidencing  the portion of this
Warrant  not  so  assigned,  and  this  Warrant  shall  promptly  be  cancelled.
Notwithstanding  anything  herein  to the  contrary,  the  Holder  shall  not be
required to physically  surrender  this Warrant to the Company unless the Holder
has assigned  this Warrant in full,  in which case,  the Holder shall  surrender
this Warrant to the Company within three (3) Trading Days of the date the Holder
delivers an assignment  form to the Company  assigning  this Warrant  full.  The
Warrant, if properly assigned in accordance herewith,  may be exercised by a new
holder for the purchase of Warrant Shares without having a new Warrant issued.

     b) New  Warrants.  This  Warrant  may be  divided  or  combined  with other
Warrants  upon  presentation  hereof at the  aforesaid  office  of the  Company,
together with a written notice  specifying the names and  denominations in which
new  Warrants  are to be issued,  signed by the Holder or its agent or attorney.
Subject  to  compliance  with  Section  4(a),  as to any  transfer  which may be
involved in such division or combination,  the Company shall execute and deliver
a new Warrant or Warrants in exchange  for the Warrant or Warrants to be divided
or combined in accordance with such notice.  All Warrants issued on transfers or
exchanges  shall be dated the original  Issue Date and shall be  identical  with
this  Warrant  except  as to the  number of  Warrant  Shares  issuable  pursuant
thereto.

     c) Warrant Register.  The Company shall register this Warrant, upon records
to be maintained by the Company for that purpose (the  "Warrant  Register"),  in
the name of the record Holder hereof from time to time. The Company may deem and
treat the registered Holder of this Warrant as the absolute owner hereof for the
purpose of any exercise hereof or any  distribution  to the Holder,  and for all
other purposes, absent actual notice to the contrary.

     d) Transfer Restrictions.  If, at the time of the surrender of this Warrant
in connection  with any transfer of this  Warrant,  the transfer of this Warrant
shall  not be  either  (i)  registered  pursuant  to an  effective  registration
statement under the Securities Act and under applicable state securities or blue
sky  laws  or  (ii)  eligible  for  resale  without  volume  or   manner-of-sale
restrictions or current public  information  requirements  pursuant to Rule 144,

                                       13
<PAGE>
the Company may require,  as a condition  of allowing  such  transfer,  that the
Holder  or  transferee  of this  Warrant,  as the case may be,  comply  with the
provisions of Section 5.7 of the Purchase Agreement.

     e)  Representation  by the Holder.  The Holder,  by the acceptance  hereof,
represents and warrants that it is acquiring this Warrant and, upon any exercise
hereof, will acquire the Warrant Shares issuable upon such exercise, for its own
account and not with a view to or for  distributing  or  reselling  such Warrant
Shares or any part thereof in violation of the  Securities Act or any applicable
state  securities law, except pursuant to sales registered or exempted under the
Securities Act.

     Section 5. Miscellaneous.

     a) No Rights as Stockholder  Until Exercise.  This Warrant does not entitle
the Holder to any voting  rights,  dividends or other rights as a stockholder of
the Company prior to the exercise hereof as set forth in Section 2(d)(i), except
as expressly set forth in Section 3.

     b) Loss, Theft, Destruction or Mutilation of Warrant. The Company covenants
that upon receipt by the Company of evidence  reasonably  satisfactory  to it of
the  loss,  theft,  destruction  or  mutilation  of this  Warrant  or any  stock
certificate  relating  to the  Warrant  Shares,  and in case of  loss,  theft or
destruction,  of indemnity or security reasonably  satisfactory to it (which, in
the case of the  Warrant,  shall not include the posting of any bond),  and upon
surrender and cancellation of such Warrant or stock  certificate,  if mutilated,
the Company  will make and deliver a new  Warrant or stock  certificate  of like
tenor  and  dated  as of such  cancellation,  in lieu of such  Warrant  or stock
certificate.

     c) Saturdays,  Sundays, Holidays, etc. If the last or appointed day for the
taking of any action or the  expiration of any right  required or granted herein
shall not be a Business Day, then, such action may be taken or such right may be
exercised on the next succeeding Business Day.

     d) Authorized Shares.

     The Company  covenants that,  during the period the Warrant is outstanding,
it will  reserve  from its  authorized  and  unissued  Common Stock a sufficient
number of shares to provide  for the  issuance  of the  Warrant  Shares upon the
exercise  of any  purchase  rights  under  this  Warrant.  The  Company  further
covenants that its issuance of this Warrant shall  constitute  full authority to
its  officers  who are charged  with the duty of issuing the  necessary  Warrant
Shares upon the exercise of the purchase rights under this Warrant.  The Company
will take all such  reasonable  action as may be  necessary  to assure that such
Warrant  Shares  may be issued  as  provided  herein  without  violation  of any
applicable law or regulation,  or of any requirements of the Trading Market upon
which the Common Stock may be listed.  The Company  represents  that all Warrant
Shares  issuable upon the exercise of the purchase  rights  represented  by this

                                       14
<PAGE>
Warrant will, upon exercise of the purchase  rights  represented by this Warrant
and requisite  payment for such Warrant Shares in accordance  herewith,  be duly
authorized,  validly  issued,  fully  paid and  nonassessable  and free from all
taxes,  liens and charges created by the Company in respect of the issue thereof
(other than taxes in respect of any transfer  occurring  contemporaneously  with
such issue).

     Except  and to the  extent as waived or  consented  to by the  Holder,  the
Company shall not by any action,  including,  without  limitation,  amending its
certificate of incorporation or through any reorganization,  transfer of assets,
consolidation,  merger,  dissolution,  issue or sale of  securities or any other
voluntary action, avoid or seek to avoid the observance or performance of any of
the terms of this  Warrant,  but will at all times in good  faith  assist in the
carrying  out of all such terms and in the taking of all such  actions as may be
necessary  or  appropriate  to protect the rights of Holder as set forth in this
Warrant against  impairment.  Without  limiting the generality of the foregoing,
the Company will (i) not increase the par value of any Warrant  Shares above the
amount payable therefor upon such exercise immediately prior to such increase in
par value, (ii) take all such action as may be necessary or appropriate in order
that the Company may  validly  and  legally  issue fully paid and  nonassessable
Warrant  Shares  upon the  exercise of this  Warrant and (iii) use  commercially
reasonable  efforts to obtain all such  authorizations,  exemptions  or consents
from  any  public  regulatory  body  having  jurisdiction  thereof,  as may  be,
necessary to enable the Company to perform its obligations under this Warrant.

     Before  taking any action which would result in an adjustment in the number
of Warrant  Shares for which this  Warrant  is  exercisable  or in the  Exercise
Price, the Company shall obtain all such  authorizations or exemptions  thereof,
or consents  thereto,  as may be necessary  from any public  regulatory  body or
bodies having jurisdiction thereof.

     e)  Jurisdiction.  All questions  concerning  the  construction,  validity,
enforcement and interpretation of this Warrant shall be determined in accordance
with the provisions of the Purchase Agreement.

     f) Restrictions.  The Holder  acknowledges that the Warrant Shares acquired
upon the exercise of this  Warrant,  if not  registered  and the Holder does not
utilize cashless  exercise,  will have restrictions upon resale imposed by state
and federal securities laws.

     g) Nonwaiver and Expenses.  No course of dealing or any delay or failure to
exercise any right  hereunder on the part of Holder shall operate as a waiver of
such right or  otherwise  prejudice  the  Holder's  rights,  powers or remedies,
notwithstanding  the fact that all rights hereunder terminate on the Termination
Date. If the Company  willfully and knowingly fails to comply with any provision
of this  Warrant,  which  results in any  material  damages to the  Holder,  the
Company shall pay to the Holder such amounts as shall be sufficient to cover any
costs and expenses  including,  but not limited to, reasonable  attorneys' fees,
including those of appellate  proceedings,  incurred by the Holder in collecting

                                       15
<PAGE>
any amounts due  pursuant  hereto or in otherwise  enforcing  any of its rights,
powers or remedies hereunder.

     h) Notices. Any notice,  request or other document required or permitted to
be given or  delivered  to the  Holder  by the  Company  shall be  delivered  in
accordance with the notice provisions of the Purchase Agreement.

     i)  Limitation  of Liability.  No provision  hereof,  in the absence of any
affirmative  action by the Holder to exercise  this Warrant to purchase  Warrant
Shares,  and no  enumeration  herein of the rights or  privileges of the Holder,
shall give rise to any  liability  of the Holder for the  purchase  price of any
Common  Stock or as a  stockholder  of the Company,  whether  such  liability is
asserted by the Company or by creditors of the Company.

     j)  Remedies.  The Holder,  in addition to being  entitled to exercise  all
rights  granted by law,  including  recovery  of  damages,  will be  entitled to
specific  performance of its rights under this Warrant.  The Company agrees that
monetary  damages  would not be adequate  compensation  for any loss incurred by
reason of a breach by it of the  provisions of this Warrant and hereby agrees to
waive and not to assert the defense in any action for specific  performance that
a remedy at law would be adequate.

     k) Successors  and Assigns.  Subject to applicable  securities  laws,  this
Warrant  and the rights and  obligations  evidenced  hereby  shall  inure to the
benefit of and be  binding  upon the  successors  and  permitted  assigns of the
Company and the  successors and permitted  assigns of Holder.  The provisions of
this  Warrant are intended to be for the benefit of any Holder from time to time
of this  Warrant  and shall be  enforceable  by the  Holder or holder of Warrant
Shares.

     l)  Amendment.  This  Warrant may be modified or amended or the  provisions
hereof waived with the written consent of the Company and the Holder.

     m) Severability. Wherever possible, each provision of this Warrant shall be
interpreted  in such manner as to be effective and valid under  applicable  law,
but if any  provision of this Warrant  shall be  prohibited  by or invalid under
applicable  law,  such  provision  shall be  ineffective  to the  extent of such
prohibition or invalidity, without invalidating the remainder of such provisions
or the remaining provisions of this Warrant.

     n) Headings.  The headings used in this Warrant are for the  convenience of
reference only and shall not, for any purpose, be deemed a part of this Warrant.

                              ********************

                            (SIGNATURE PAGE FOLLOWS)

                                       16
<PAGE>
     IN WITNESS  WHEREOF,  the Company has caused this Warrant to be executed by
its officer thereunto duly authorized as of the date first above indicated.

                         STEVIA CORP.

                         By:____________________________________
                            Name: George Blankenbaker
                            Title: President

                                       17Exhibit 10.1

Exhibit 10.1

DEBT CONVERSION AGREEMENT

This DEBT CONVERSION AGREEMENT (this “Agreement”) is dated December 29, 2014 (the “Effective Date”), by and between Alexander Bafer (“Holder”) and Brick Top Productions, Inc., a Florida corporation (“Brick Top”).

R E C I T A L S:

WHEREAS, Brick Top owes the Holder a total of $100,000.00 for outstanding loan (the “Debt”); and

WHEREAS, Holder desires to convert the Debt into shares of Brick Top’s common stock, $0.0001 par value per share (the “Common Stock”) at a conversion price of $.005 per share and Brick Top desires to issue its Common Stock to Holder in exchange for the Debt.

WHEREAS, Holder and Brick Top intend this conversion to be completed pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended.

NOW, THEREFORE, in consideration of the premises and of the terms and conditions herein contained, the parties mutually agree as follows:

1.  Conversion of Debt.

1.1   As of the Effective Date, the Debt shall be converted into 20,000,000 shares of Common Stock (the “Shares”).

2.  Representations and Warranties of Brick Top.

2.1   Authorization.    The execution, delivery and performance by Brick Top of this Agreement and the performance of all of Brick Top’s obligations hereunder have been duly authorized by all necessary corporate action, and this Agreement has been duly executed and delivered by Brick Top. This Agreement constitutes the valid and binding obligation of Brick Top enforceable in accordance with its terms. The execution and performance of the transactions contemplated by this Agreement and compliance with its provisions by Brick Top will not conflict with or result in any breach of any of the terms, conditions, or provisions of, or constitute a default under, its articles of incorporation or bylaws or any agreement to which Brick Top is a party or by which it or any of its properties is bound.

2.2   Issuance of Shares.    The issuance and delivery of Shares in accordance with this Agreement has been duly authorized by all necessary corporate action on the part of Brick Top, and the Shares, when so delivered, will have been duly and validly authorized and issued by the Company and will be fully paid and nonassessable.

2.3   Binding Obligation.    Assuming the due execution and delivery of this Agreement, this Agreement constitutes the valid and binding obligation of Brick Top, enforceable against Brick Top in accordance with its terms, subject, as to enforcement, (i) to bankruptcy, insolvency, reorganization, arrangement, moratorium and other laws of general applicability relating to or affecting creditors' rights and (ii) to general principles of equity, whether such enforceability is considered in a proceeding in equity or at law.

3.  Miscellaneous.

3.1   No Third Party Beneficiaries.    This Agreement shall not confer any rights or remedies upon any person other than the parties and their respective successors and permitted assigns.

3.2   Entire Agreement.    This Agreement (including the documents referred to herein) constitutes the entire agreement among the parties and supersedes any prior understandings, agreements, or representations by or among the parties, written or oral, to the extent they related in any way to the subject matter hereof.

3.3   Counterparts.    This agreement may be executed in one or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.

3.4   Governing Law.    This Agreement shall be governed by and construed in accordance with the laws of the State of Florida (without regard to conflict of laws).

3.5   No Waiver/Amendments.    Any waiver by either party to this Agreement of any provision of this Agreement shall not be construed as a waiver of any other provision of this Agreement, nor shall such waiver be construed as a waiver of such provision respecting any future event or circumstance. No amendment of any provision of this Agreement shall be valid unless the same shall be in writing and signed by both parties.

3.6   Severability.    Any term or provision of this Agreement that is invalid or unenforceable in any situation in any jurisdiction shall not affect the validity or enforceability of the remaining terms and provisions hereof or the validity or enforceability of the offending term or provision in any other situation or in any other jurisdiction.

3.7   Costs.    Each party will bear the costs and expenses incurred by it in connection with this Agreement and the transaction contemplated thereby.

3.8   Survival of Terms.    All representations, warranties and covenants contained in this Agreement or in any certificates or other instruments delivered by or on behalf of the parties hereto shall be continuous and survive the execution of this Agreement.

3.9   Assignment.    This Agreement shall be binding upon the parties hereto and their respective successors and assigns and shall inure to the benefit of any assignee, subject to the terms and conditions hereof.

3.10   Headings.    The headings used in this Agreement are for convenience only and shall not by themselves determine the interpretation, construction or meaning of this Agreement.

3.12   Additional Assurances.    Holder agrees to furnish to Brick Top, promptly upon Brick Top's written request therefore, such additional documents or instruments, if any, in connection with the conversion of the Debt into the Common Stock, Brick Top, or its agent may require.

3.13   Attorneys Fees and Costs.    In the event any party to this Agreement shall be required to initiate legal proceedings to enforce performance of any term or condition of this Agreement, including, but not limited to, the interpretation of any term or provision hereof, the payment of moneys or the enjoining of any action prohibited hereunder, the prevailing party shall be entitled to recover such sums in addition to any other damages or compensation received, as will reimburse the prevailing party for reasonable attorneys’ fees and court costs incurred on account thereof (including, without limitation, the costs of any appeal) notwithstanding the nature of the claim or cause of action asserted by the prevailing party.

- 2 -

IN WITNESS WHEREOF, the Holder and Brick Top have caused this Agreement to be executed as of the day and year first above written.

			
	 
	HOLDER

	 
	 
	 

	 
	 
	 

	 
	 
	 

	 
	By:

	/s/ Alexander Bafer

	 
	 
	Alexander Bafer

	 
	 
	 

	 
	 
	 

	 
	Brick Top Productions, Inc.

	 
	 
	 

	 
	By:

	/s/ Alexander Bafer

	 
	Name:

	Alexander Bafer

	 
	Title:

	CEO

- 3 -

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00239-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00239-of-00352.parquet"}]]